000			02379cam a22002538i 4500
001			23126166
005			20250616124159.0
008			230512s2023 enk b 001 0 eng
010			_a 2023013755
020			_a9781804291450 _q(hardback)
040			_aDLC _beng _erda _cDLC
041			_aeng
042			_apcc
050	0	0	_aHD9665.5 _b.D396 2023
100			_aDearden, Nick, _eauthor. _925393
245	1	0	_aPharmanomics _b: how big pharma threatens global health _c/ Nick Dearden.
264		1	_aLondon ; _aNew York : _bVerso, _c2023.
300			_a315 p. ; 24 cm
504			_aIncludes bibliographical references and index.
505	0		_aA History of Scandal — A Hedge Fund with a Pharmaceutical Firm Attached — It Was Greed, My Friends — The Pandemic Begins — Recolonising the Global Economy — The Hospital That Became a Trading Floor — A New Hope — Reach for the Moon.
520			_aIn Pharmanomics, investigative journalist Nick Dearden digs down into the way we produce our medicines and finds that Big Pharma is failing us, with catastrophic consequences. Big Pharma is more interested in profit than health. This was made clear as governments rushed to produce vaccines during the Covid pandemic. Behind the much-trumpeted scientific breakthroughs, major companies found new ways of gouging billions from governments in the West while abandoning the Global South. But this is only the latest episode in a long history of financialising medicine – from Purdue's rapacious marketing of highly addictive OxyContin through Martin Shkreli's hiking the price of a lifesaving drug to the 4.5 million South Africans needlessly deprived of HIV/AIDS medication. Since the 1990s, Big Pharma has gone out of its way to protect its property through the patent system. As a result, the business has focused not on researching new medicines but on building monopolies. This system has helped restructure our economy away from invention and production in order to benefit financial markets. It has fundamentally reshaped the relationship between richer and poorer countries, as the access to new medicines and the permission to manufacture them is ruthlessly policed. In response, Dearden offers a pathway to a fairer, safer system for all. _cProvided by publisher.
650		0	_aPharmaceutical industry _xMoral and ethical aspects.
942			_2lcc
999			_c4719 _d4719